{"id":"https://openalex.org/W4308977207","doi":"https://doi.org/10.1093/neuonc/noac209.1012","title":"TMET-07. MOLECULAR MECHANISM OF EXQUISITE SENSITIVITY OF DIFFUSE MIDLINE GLIOMA TO DE NOVO PYRIMIDINE BIOSYNTHESIS","display_name":"TMET-07. MOLECULAR MECHANISM OF EXQUISITE SENSITIVITY OF DIFFUSE MIDLINE GLIOMA TO DE NOVO PYRIMIDINE BIOSYNTHESIS","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4308977207","doi":"https://doi.org/10.1093/neuonc/noac209.1012"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noac209.1012","doi":"https://doi.org/10.1093/neuonc/noac209.1012","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noac209.1012","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii262/47021811/noac209.1012.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii262/47021811/noac209.1012.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048318552","display_name":"Sharmistha Pal","orcid":"https://orcid.org/0000-0001-5391-5149","observed_orcids":["https://orcid.org/0000-0001-5391-5149"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharmistha Pal","raw_affiliation_strings":["Dana Farber Cancer Institute , Hopkinton, MA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute , Hopkinton, MA , USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030101658","display_name":"Milan R. Savani","orcid":"https://orcid.org/0000-0003-1776-451X","observed_orcids":["https://orcid.org/0000-0003-1776-451X"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Milan Savani","raw_affiliation_strings":["University of Texas Southwestern Medical Center , Dallas, TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern Medical Center , Dallas, TX , USA","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109308536","display_name":"Jakub Kaplan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jakub Kaplan","raw_affiliation_strings":["Dana Farber Cancer Institute , Boston , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute , Boston , USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061890301","display_name":"Sylwia A. Stopka","orcid":"https://orcid.org/0000-0003-3761-6899","observed_orcids":["https://orcid.org/0000-0003-3761-6899","https://orcid.org/0000-0002-7579-8905"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sylwia Sylwia A Stopka","raw_affiliation_strings":["Brigham and Women's Hospital , Boston , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital , Boston , USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005950027","display_name":"Huy Q. Nguyen","orcid":"https://orcid.org/0000-0002-4424-1047","observed_orcids":["https://orcid.org/0000-0002-4424-1047"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Huy Nguyen","raw_affiliation_strings":["Dana Farber Cancer Institute , Boston , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute , Boston , USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075621139","display_name":"Michael Scott Regan","orcid":"https://orcid.org/0000-0001-5252-2829","observed_orcids":["https://orcid.org/0000-0001-5252-2829"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Regan","raw_affiliation_strings":["Brigham and Women's Hospital , Boston , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital , Boston , USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046979141","display_name":"Nathalie Y.R. Agar","orcid":"https://orcid.org/0000-0003-3149-3146","observed_orcids":["https://orcid.org/0000-0003-3149-3146"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathalie Agar","raw_affiliation_strings":["Brigham and Women's Hospital , Boston , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital , Boston , USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022454220","display_name":"Samuel K. McBrayer","orcid":"https://orcid.org/0000-0001-9361-675X","observed_orcids":["https://orcid.org/0000-0001-9361-675X"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel McBrayer","raw_affiliation_strings":["University of Texas Southwestern Medical Center , Dallas, TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern Medical Center , Dallas, TX , USA","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085032736","display_name":"Daphne Adele Haas-Kogan","orcid":"https://orcid.org/0000-0002-2378-4800","observed_orcids":["https://orcid.org/0000-0002-2378-4800"]},"institutions":[{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daphne Haas-Kogan","raw_affiliation_strings":["Dana-Farber/Boston Children's Cancer and Blood Disorders Center , Boston, MA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center , Boston, MA , USA","institution_ids":["https://openalex.org/I4210166317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4612,"currency":"USD","value_usd":4612},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"Supplement_7","first_page":"vii262","last_page":"vii262"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.9047999978065491,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.9047999978065491,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.07410000264644623,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-midline-glioma","display_name":"diffuse midline glioma","score":1.0},{"id":"https://openalex.org/keywords/de-novo-pyrimidine-synthesis","display_name":"de novo pyrimidine biosynthesis","score":0.9869999885559082},{"id":"https://openalex.org/keywords/dihydropyrimidine-dehydrogenase","display_name":"dihydropyrimidine dehydrogenase","score":0.8550000190734863},{"id":"https://openalex.org/keywords/pyrimidine-degradation","display_name":"pyrimidine degradation","score":0.8840000033378601},{"id":"https://openalex.org/keywords/ump","display_name":"UMP","score":0.6470000147819519},{"id":"https://openalex.org/keywords/crispr-screening","display_name":"CRISPR screen","score":0.7039999961853027},{"id":"https://openalex.org/keywords/metabolic-dependencies","display_name":"metabolic dependencies","score":0.6639999747276306},{"id":"https://openalex.org/keywords/dna-damage","display_name":"DNA damage","score":0.906000018119812},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.7440000176429749},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7580000162124634},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5899999737739563}],"concepts":[{"id":"https://openalex.org/C200159599","wikidata":"https://www.wikidata.org/wiki/Q4893563","display_name":"Pyrimidine metabolism","level":4,"score":0.820502519607544},{"id":"https://openalex.org/C88742014","wikidata":"https://www.wikidata.org/wiki/Q1063702","display_name":"De novo synthesis","level":3,"score":0.7444859743118286},{"id":"https://openalex.org/C2779321679","wikidata":"https://www.wikidata.org/wiki/Q207722","display_name":"Pyrimidine","level":2,"score":0.6017025709152222},{"id":"https://openalex.org/C2779655350","wikidata":"https://www.wikidata.org/wiki/Q1114455","display_name":"DPYD","level":5,"score":0.5403727293014526},{"id":"https://openalex.org/C512185932","wikidata":"https://www.wikidata.org/wiki/Q28745","display_name":"Nucleotide","level":3,"score":0.5021576881408691},{"id":"https://openalex.org/C194101687","wikidata":"https://www.wikidata.org/wiki/Q583813","display_name":"Nucleotide salvage","level":4,"score":0.4940676987171173},{"id":"https://openalex.org/C64241487","wikidata":"https://www.wikidata.org/wiki/Q5205774","display_name":"DNA synthesis","level":3,"score":0.4889165461063385},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4763239324092865},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4258129596710205},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41381555795669556},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.2929866909980774},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.24106568098068237},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.15046286582946777},{"id":"https://openalex.org/C2776476023","wikidata":"https://www.wikidata.org/wiki/Q188261","display_name":"Purine","level":3,"score":0.08618417382240295},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.0},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noac209.1012","doi":"https://doi.org/10.1093/neuonc/noac209.1012","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noac209.1012","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii262/47021811/noac209.1012.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9661227","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9661227","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noac209.1012","doi":"https://doi.org/10.1093/neuonc/noac209.1012","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noac209.1012","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii262/47021811/noac209.1012.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308977207.pdf","grobid_xml":"https://content.openalex.org/works/W4308977207.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3144797517","https://openalex.org/W4292240378","https://openalex.org/W3168027276","https://openalex.org/W6963117544","https://openalex.org/W4309413236","https://openalex.org/W4296700305","https://openalex.org/W3111534336","https://openalex.org/W4416140149","https://openalex.org/W4394618759","https://openalex.org/W4292242254"],"abstract_inverted_index":{"Abstract":[0],"Diffuse":[1],"midline":[2],"glioma":[3],"(DMG)":[4],"is":[5],"a":[6,28,41,61,64,264],"lethal":[7],"pediatric":[8],"brain":[9],"cancer":[10],"in":[11,71,77,129,161,167,180,211,245],"dire":[12],"need":[13],"for":[14,24,138],"therapeutic":[15,22],"breakthroughs.":[16],"To":[17,152],"identify":[18],"intrinsic":[19],"addictions":[20],"and":[21,52,92,135,203,231],"targets":[23],"DMG,":[25,168],"we":[26,169,240,259],"conducted":[27],"genome-wide":[29],"k\u00ac\u00ac\u00ac\u00acnockout":[30],"CRISPR":[31],"screen":[32],"that":[33,97,132,247],"identified":[34],"de":[35,53,68,107,149,163,194,218,253,270],"novo":[36,54,69,108,150,164,195,219,254,271],"pyrimidine":[37,45,74,117,127,139,159,181,220,255,272],"biosynthesis":[38],"pathway":[39,70,165,196],"as":[40,60,198,263],"targetable":[42],"dependency.":[43],"Since":[44],"nucleotides":[46],"can":[47],"be":[48],"synthesized":[49],"by":[50,226],"salvage":[51,141],"pathways,":[55],"identification":[56],"of":[57,67,90,103,122,158,187,191,209,229,233,243,252,267],"the":[58,73,81,101,116,146,155,173,176],"latter":[59],"dependency":[62,86,147,166],"indicated":[63],"prominent":[65],"role":[66,157],"establishing":[72],"nucleotide":[75,140],"pool":[76],"DMG.":[78],"We":[79,95],"investigated":[80],"molecular":[82],"mechanism":[83],"underlying":[84],"this":[85,238],"using":[87,183],"metabolic":[88],"tracing":[89],"15N-glutamine":[91],"genetic":[93],"approaches.":[94],"report":[96],"DMG":[98],"cells":[99],"derive":[100],"majority":[102],"UMP":[104,125,201,230],"(70%)":[105],"through":[106,115,126],"synthesis,":[109],"along":[110],"with":[111,237],"significantly":[112],"elevated":[113],"flux":[114,121],"degradation":[118,128,160],"pathway.":[119],"High":[120],"15N-":[123],"labeled":[124],"DMGs":[130,192,246],"suggests":[131],"substrates":[133],"(uridine":[134],"uracil)":[136],"required":[137],"are":[142],"limited,":[143],"thus":[144],"enhancing":[145],"on":[148],"biosynthesis.":[151],"further":[153],"confirm":[154],"causal":[156],"driving":[162],"knocked":[170],"down":[171],"DPYD,":[172],"enzyme":[174],"catalyzing":[175],"first":[177],"committed":[178],"step":[179],"degradation,":[182],"inducible":[184],"shRNAs.":[185],"Knockdown":[186],"DPYD":[188,210,244,262],"diminished":[189],"sensitivity":[190,216,268],"to":[193,217,250,269],"inhibition":[197,222],"it":[199],"rescued":[200],"pools":[202],"resultant":[204],"DNA":[205,234],"damage.":[206,235],"Conversely,":[207],"overexpression":[208],"adult":[212],"glioblastomas":[213],"enhanced":[214],"their":[215],"synthesis":[221,273],"which":[223],"was":[224],"accompanied":[225],"greater":[227],"depletion":[228],"induction":[232],"Consistent":[236],"mechanism,":[239],"observed":[241],"downregulation":[242],"acquired":[248],"resistance":[249],"antagonists":[251],"synthesis.":[256],"Taken":[257],"together,":[258],"have":[260],"uncovered":[261],"predictive":[265],"biomarker":[266],"inhibitors.":[274]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2022-11-20T00:00:00"}